Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Anat Rec (Hoboken) ; 306(12): 3021-3032, 2023 12.
Artículo en Inglés | MEDLINE | ID: mdl-35661433

RESUMEN

Asthenozoospermia is a leading cause of male infertility, characterized by reduced sperm motility. In this study, we determined sperm motility and the activities of antioxidant enzymes and oxidation products in the testis of rats with ornidazole (ORN)-induced asthenozoospermia and further examined and compared the differential effects of moxa smoke (MS) and cigarette smoke (CS) on sperm motility and oxidative stress (OS) of asthenozoospermic rats. The smoke intervention was initiated 11 days after intragastric administration of ORN, followed by the examination of testis index, sperm parameters, OS-related gene levels, and testicular histopathology. Sperm motility and antioxidant enzyme activities, as well as oxidation products significantly decreased in ORN-induced rats compared with MS-treated rats (p < .05-.001). MS treatment restored the reduced sperm motility and activities of glutathione peroxidase, superoxide dismutase, and catalase, but increased the malondialdehyde and nitric oxide synthetase levels in ORN-induced rats (p < .05-.001). Also, the histopathological changes in the testis of ORN-induced rats were improved by MS treatment. The study highlighted that MS was an effective factor in moxibustion therapy, which notably improved the sperm motility of asthenozoospermic rats by inhibiting OS in the reproductive system.


Asunto(s)
Astenozoospermia , Ornidazol , Humanos , Ratas , Masculino , Animales , Antioxidantes/farmacología , Astenozoospermia/inducido químicamente , Astenozoospermia/metabolismo , Astenozoospermia/patología , Recuento de Espermatozoides , Motilidad Espermática , Semen , Espermatozoides , Testículo/metabolismo , Estrés Oxidativo , Ornidazol/efectos adversos , Ornidazol/metabolismo
2.
J Tradit Chin Med ; 41(4): 581-587, 2021 08.
Artículo en Inglés | MEDLINE | ID: mdl-34392651

RESUMEN

OBJECTIVE: To investigate the efficacy of Runjing (RJ) extract on oligoasthenoteratozoospermia (OAT) induced by ornidazole (ORN) in rats, and to study the underlying mechanism. METHODS: Twenty-four adult male Sprague-Dawley rats were treated with normal saline (control), ORN (OAT model), ORN + 4.725 g·kg-1·d-1 RJ extract (low-dose) and ORN+ 18.9 g·kg-1·d-1 RJ extract (high-dose) for 4 weeks. The rats were then euthanized and sperm and testis samples were collected for analysis. Sperm count, motility and morphology were calculated by sperm suspension from cauda epididymis. Testicular histopathological changes were analyzed by hematoxylin and eosin staining and TdT mediated dUTP nick end labelling. Moreover, the expression of vimentin and extracellular signal-regulated kinase (ERK) were examined through Western blot, and the distribution of vimentin was detected via immunohistochemistry. RESULTS: ORN successfully induces seminiferous epithelium injury, cellular apoptosis, and finally OAT (P < 0.05). However, both low-dose and highdose RJ extract partially rescues the phenotypes (P < 0.05). Moreover, the expressions of vimentin and ERK were significantly altered in ORN testes (all P < 0.001), while RJ extract partially reversed these effects (P < 0.01 or P < 0.001). CONCLUSION: RJ extract can help maintain spermatogenesis through ERK signalling, and regulating vimentin expression.


Asunto(s)
Astenozoospermia , Infertilidad Masculina , Oligospermia , Ornidazol , Animales , Astenozoospermia/tratamiento farmacológico , Astenozoospermia/genética , Quinasas MAP Reguladas por Señal Extracelular/genética , Infertilidad Masculina/tratamiento farmacológico , Infertilidad Masculina/genética , Masculino , Ornidazol/efectos adversos , Extractos Vegetales , Ratas , Ratas Sprague-Dawley , Motilidad Espermática , Espermatogénesis , Vimentina/genética
3.
Adv Exp Med Biol ; 1155: 507-520, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31468427

RESUMEN

Asthenospermia has been considered as one of the crucial causes of male infertility, which was closely related to epididymal dysfunction. Lots of documents have revealed that taurine palys an important role in male reproduction, including antioxidation, membrane stabilization, stimulation of sexual hormone secretion and elevation of sperm quality. The objective of this study was to expose the effect of taurine on spermatozoa quality and function in ornidazole-induced asthenospermia rats. We found that taurine treatment could obviously recover the decline of cauda epididymal sperm count, viability and motility, and the elevation of sperm abnormality in asthenospermia animals. Spermatozoa acrosin, LDH-X, SDH and CCO activities of model rats also were notably increased by taurine administration. The present data indicated that taurine could raise spermatozoa quality and function by elevating mitochondrial energy metabolism. Notably, taurine supplementation markedly raised serum GnRH, LH and T levels in asthenospermia rays, suggesting taurine rescued asthenosperm by means of stimulating hypothalamic-pituitary-testicular axis secretion. We also found that concentrations of asthenospermia epididymal carnitine, SA, α-Glu and ACP, and mRNA expression levels of MMP7 and IDO2 were significantly rised by taurine administration, indicating taurine may protect epididymal epithelium structure, improve secretion activity, and maintain intraluminal microenvironment homeostasis. Finally, the present results showed taurine effectively increased cauda epididymal SOD, GSH and γ-GT levels in model rats, reduced ROS and MDA production, suggesting epididymal antioxidant ability of asthenospermia rats could be elevated by taurine treatment. To sum up, our results indicated that taurine can promote spermatozoa quality and function in ornidazole-induced asthenospermia rats by facilitating epididymal epithelium secretion and luminal microenvironment homeostasis.


Asunto(s)
Astenozoospermia/tratamiento farmacológico , Ornidazol/efectos adversos , Espermatozoides/efectos de los fármacos , Taurina/farmacología , Animales , Astenozoospermia/inducido químicamente , Epidídimo/efectos de los fármacos , Epidídimo/fisiopatología , Masculino , Ratas , Motilidad Espermática , Espermatozoides/citología
4.
Zhonghua Nan Ke Xue ; 15(7): 604-7, 2009 Jul.
Artículo en Chino | MEDLINE | ID: mdl-19694372

RESUMEN

OBJECTIVE: To explore the protective effect of L-carnitine (LC) on the reproductive function of male rats with asthenospermia induced by ornidazole (ORN). METHODS: Forty male SD rats (200-230 g) were randomly divided into Groups A (control: 0.5% carboxymethylcellulose solution), B (medium-dose ORN: 400 mg/kg/d), C (medium-dose ORN + LC: ORN 400 mg/kg/d + LC 100 mg/kg/d), D (high-dose ORN: 800 mg/kg/d), and E (high-dose ORN + LC: ORN 800 mg/kg/d + LC 100 mg/kg/d). All the rats were treated via gastric gavage for 20 days consecutively, and then killed for the detection of sperm motility and the sperm count of the cauda epididymis. RESULTS: Compared with Group A, there was a significant decrease in sperm motility and sperm count in Groups B and D (P < 0.05), while Group C showed a significant increase in both the parameters as compared with B (P < 0.05), but with no significant difference from A (P > 0.05). Group E exhibited no obvious improvement in sperm motility and sperm count, with no difference from D (P > 0.05). CONCLUSION: L-carnitine can improve the sperm motility and sperm count of the male rats with ornidazole-induced asthenospermia.


Asunto(s)
Astenozoospermia/tratamiento farmacológico , Carnitina/uso terapéutico , Animales , Astenozoospermia/inducido químicamente , Masculino , Ornidazol/efectos adversos , Ratas , Ratas Sprague-Dawley , Recuento de Espermatozoides , Motilidad Espermática , Resultado del Tratamiento
5.
J Antimicrob Chemother ; 11(3): 207-15, 1983 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-6404880

RESUMEN

A double blind, randomized study comprising 60 patients was undertaken to compare the efficacy of ornidazole to that of phenoxymethylpenicillin in the treatment of orofacial infections. Thirty patients received ornidazole 500 mg orally every 12 h for seven days and were all cured in less than seven days. Five of the 30 patients receiving penicillin, 800 mg orally every 12 h for seven days, did not respond satisfactorily to the treatment given. In two of these instances, beta-lactamase-producing penicillin-resistant Bacteroides strains were isolated. In the present study, ornidazole was found to be more efficient than penicillin in the treatment of orofacial infections. Anaerobes were isolated from all specimens except four that yielded no growth. Anaerobes only were isolated from 65% of the specimens. Since ornidazole was efficient in all cases when given, it is concluded that anaerobic bacteria are the causal pathogens in most orofacial infections.


Asunto(s)
Infecciones Bacterianas/tratamiento farmacológico , Nitroimidazoles/uso terapéutico , Ornidazol/uso terapéutico , Penicilina V/uso terapéutico , Estomatitis/tratamiento farmacológico , Adulto , Aerobiosis , Anciano , Anaerobiosis , Infecciones Bacterianas/microbiología , Cara , Femenino , Humanos , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Ornidazol/efectos adversos , Estomatitis/microbiología , beta-Lactamasas/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA